Flagship Ventures Fund IV General Partner LLC is 10% Owner at Evelo Biosciences, Inc. (EVLO). They have made 3 open-market trades across 2 companies since 2018, most recently 2023-07-11.
3 open-market purchases totalling $34.5M since 2018, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.